Table 3 Diagnostic value of miR-206 in cancers
From: Emerging roles and mechanisms of miR-206 in human disorders: a comprehensive review
Type of disease | Number of samples | Distinguish between | Area under curve | Sensitivity (%) | Specificity (%) | Refs. |
|---|---|---|---|---|---|---|
Epithelial ovarian cancer (EOC) | 56 EOC patients | 27 incomplete response (IR) EOC patients vs. 29 complete response (CR) patients | 0.829 | – | – | [32] |
Renal cell cancer (RCC) | 18 ccRCC and 8 patients with benign renal tumors (BRT); validation cohort: 68 ccRCC, 47 BRT, and 28 healthy cases | ccRCC patients vs. healthy controls | 0.733 | 83.8 | 57.1 | [52] |
Rhabdomyosarcoma (RMS) | 10 patients with RMS, 28 patients with other pediatric tumors and 17 healthy cases | Pediatric tumor patients vs. healthy volunteers | 0.967 | 100 | 91.3 | [53] |